Related Experiment Videos

Gram-negative bacterial pathogens: determinants of virulence and antimicrobial immunity, symposium. Introduction

P F Bonventre¹

¹Department of Microbiology and Molecular Genetics, University of Cincinnati Medical Center, Ohio.

Pathology and Immunopathology Research

|January 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution.

Protein science : a publication of the Protein Society·1996

A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.

Infection and immunity·1995

Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Infection and immunity·1995

Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells.

Infection and immunity·1995

A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.

Infection and immunity·1995

A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.

Pathobiology : journal of immunopathology, molecular and cellular biology·1995

See all related articles